Moreover, we showed that UCP-2 inhibitor Genipin might enhance the tumor suppression effects of trastuzumab and induce apoptosis in BT474 cells, shedding some light on the development of novel combination therapy against trastuzumab resistance HER2 + breast cancer. This evidence concerns the gene UCP2 and breast carcinoma.